Jaguar Health (JAGX) Current Deferred Revenue (2014 - 2026)
Jaguar Health (JAGX) posted quarterly Current Deferred Revenue of $170000.0 for Q1 2026, little changed year-over-year from $170000.0 in Q1 2025, and little changed quarter-over-quarter from $170000.0 in Q4 2025.
Jaguar Health (JAGX) Current Deferred Revenue (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported Current Deferred Revenue for 8 consecutive years, with $170000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Deferred Revenue changed 0.0% year-over-year to $170000.0; the TTM figure through Mar 2026 stood at $170000.0 (changed 0.0% YoY), while the FY2025 annual figure was $170000.0, changed 0.0% from the prior year.
- Current Deferred Revenue held at $170000.0 in Q1 2026 per JAGX's latest filing, from $170000.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $170000.0 in Q1 2024 and bottomed at $170000.0 in Q1 2024.
- Historically, Current Deferred Revenue has averaged $170000.0 across 3 years, with a median of $170000.0 in 2024.
- On a YoY basis, Current Deferred Revenue climbed as much as 0.0% in 2025 and fell as far as 0.0% in 2025.
- Jaguar Health's Current Deferred Revenue stood at $170000.0 in 2024, then changed by 0.0% to $170000.0 in 2025, then changed by 0.0% to $170000.0 in 2026.
- Business Quant data shows JAGX's Current Deferred Revenue at $170000.0 in Q1 2026, $170000.0 in Q4 2025, and $170000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Jaguar Health | 447,549.24 | -9.62 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 170,000.00 |
| Dec 31, 2025 | 170,000.00 |
| Sep 30, 2025 | 170,000.00 |
| Jun 30, 2025 | 170,000.00 |
| Mar 31, 2025 | 170,000.00 |
| Dec 31, 2024 | 170,000.00 |
| Sep 30, 2024 | 170,000.00 |
| Jun 30, 2024 | 170,000.00 |
| Mar 31, 2024 | 170,000.00 |
| Jun 30, 2020 | 1.50 Mn |
| Dec 31, 2017 | 177,389.00 |
| Sep 30, 2017 | 224,448.00 |
| Jun 30, 2017 | 184,674.00 |
| Mar 31, 2017 | 208,258.00 |
| Dec 31, 2016 | 224,454.00 |
| Sep 30, 2016 | 246,235.00 |
| Jun 30, 2016 | 262,666.00 |
| Mar 31, 2016 | 279,065.00 |
| Dec 31, 2015 | 251,936.00 |
| Sep 30, 2015 | 336,712.00 |